CVS Health Foundation Grants the American Diabetes Association $2.6 Million to Expand Maternal Diabetes Program Across Two Additional NYC Communities

Rhea-AI Summary

CVS (NYSE:CVS) announced a $2.6 million grant from the CVS Health Foundation to the American Diabetes Association to expand a maternal diabetes program into two additional New York City communities on Jan 14, 2026.

The expansion builds on 18 months of work that improved early gestational diabetes screening and care coordination for hundreds of patients at Wyckoff Heights Medical Center. Over the next three years the program will scale EMR dashboards, increase access to continuous glucose monitoring and medically tailored meals, deliver multilingual education, and track patients from pregnancy through postpartum to measure outcomes.

Positive

• $2.6M grant to expand maternal diabetes program
• Expansion to two additional NYC communities
• 18 months of prior results with improved early GDM screening for hundreds
• Three-year focus on EMR dashboards, CGM access, and MTMs
• Longitudinal tracking from pregnancy through postpartum to measure outcomes

Negative

• None.

News Market Reaction

-1.67%

1 alert

-1.67% News Effect

On the day this news was published, CVS declined 1.67%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Grant amount: $2.6 million Program duration: 18 months GDM prevalence: Up to 9% +5 more

8 metrics

Grant amount $2.6 million CVS Health Foundation grant to American Diabetes Association

Program duration 18 months Initial phase of maternal diabetes initiative at Wyckoff Heights

GDM prevalence Up to 9% Share of pregnancies nationwide affected by gestational diabetes

NYC GDM 2016 6% Gestational diabetes rate in New York City in 2016

NYC GDM 2021 8.3% Gestational diabetes rate in New York City in 2021

Bushwick diabetes rate 19% Adults with diabetes in Bushwick, Brooklyn

Avoidable hospitalizations 70% higher Bushwick vs New York City average for avoidable hospitalizations

High A1C patients 56% above 9% Wyckoff Heights patients with A1C above 9%

Market Reality Check

Price: $76.32 Vol: Volume 7,605,462 vs 20-da...

normal vol

$76.32 Last Close

Volume Volume 7,605,462 vs 20-day average 6,077,447 ahead of this announcement. normal

Technical Trading above 200-day MA at $71.37, with price at $80.68 and 5.25% below 52-week high.

Peers on Argus

While CVS shows a modest +0.4% move, key peers CI, ELV, HUM, CNC, and MOH each s...

While CVS shows a modest +0.4% move, key peers CI, ELV, HUM, CNC, and MOH each show negative price changes today, pointing to stock-specific strength rather than a sector-wide move.

Historical Context

5 past events · Latest: Jan 09 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 09	Earnings call notice	Neutral	-0.4%	Scheduled Q4 and full-year 2025 earnings conference call announcement.
Jan 06	Dividend declaration	Positive	+0.3%	Board approved quarterly dividend of $0.665 per share with set pay date.
Dec 11	Public health initiative	Positive	+2.4%	Expansion of MMR vaccine access at 200+ South Carolina CVS locations.
Dec 09	Guidance & strategy	Positive	+2.2%	Raised 2025 guidance and issued 2026 outlook at Investor Day event.
Dec 05	Economic impact report	Positive	-1.5%	Report of $474B U.S. economic impact and broad community investments.

Pattern Detected

Recent CVS headlines with constructive or shareholder-friendly tone have mostly seen aligned positive price reactions, with only one notable divergence on a broadly positive economic impact report.

Recent Company History

Over the past two months, CVS has highlighted strategic and financial strength, including updated 2025–2026 guidance with revenue of at least $400.0B and adjusted operating income targets above $14B (Dec 9, 2025). A dividend declaration on Jan 6, 2026 and community-focused initiatives like measles vaccinations and a $474 billion economic impact report reinforce its integrated health and community role. Today’s maternal diabetes grant fits this pattern of public health engagement alongside large-scale health plan and pharmacy operations.

Market Pulse Summary

This announcement highlights a $2.6 million CVS Health Foundation grant to expand a maternal diabete...

Analysis

This announcement highlights a $2.6 million CVS Health Foundation grant to expand a maternal diabetes program across additional New York City communities, building on 18 months of documented success. It reinforces CVS’s broader role in public health seen in prior vaccine and economic impact initiatives. Key elements include greater use of continuous glucose monitoring, medically tailored meals, and enhanced electronic medical records. Investors may watch how such programs support CVS’s long-term integrated health strategy and brand equity.

Key Terms

gestational diabetes, a1c, electronic medical records, continuous glucose monitoring, +1 more

5 terms

gestational diabetes medical

"diagnosed with gestational diabetes early in her pregnancy."

A form of high blood sugar that develops during pregnancy when the body cannot make or use enough insulin to control glucose levels, like a temporary traffic jam in the body’s sugar-control system. It matters to investors because it drives demand for prenatal testing, glucose monitors, medications and postnatal care, and can influence long-term healthcare costs and market size for related products and services.

a1c medical

"56% have an A1C above 9%, signaling dangerously poor blood sugar control."

A1C is a blood test that reports average blood sugar over about three months by measuring how much glucose sticks to hemoglobin, a protein in red blood cells. For investors, A1C acts like a long-term scorecard for diabetes treatments, devices and diagnostics: meaningful changes in A1C in clinical studies can affect regulatory approval, insurance coverage and commercial prospects, and thus influence a company's market value.

electronic medical records technical

"build enhanced electronic medical records (EMR) dashboards to streamline referrals"

Electronic medical records are digital versions of a patient’s health file created and kept by a single healthcare provider, containing diagnoses, medications, lab results, treatment notes and billing codes. They matter to investors because the software and services that create, store and analyze these records can generate steady revenue, lower provider costs, enable faster decision-making and carry regulatory and cybersecurity risks; think of EMRs as the digital filing cabinet that underpins many healthcare operations.

continuous glucose monitoring medical

"increase access to advanced diabetes technology, including continuous glucose monitoring (CGM)"

Continuous glucose monitoring is a system that tracks blood sugar levels in real-time throughout the day and night. It provides constant updates, similar to a car's dashboard showing speed and fuel level at all times. For investors, advancements in this technology can signal progress in health monitoring devices, which may influence the growth and valuation of companies in the healthcare sector.

medically tailored meals medical

"provide medically tailored meals (MTMs) to address patients' food insecurity"

Meals planned and prepared to meet the specific nutrition needs of people with medical conditions, like diabetes, heart disease, or kidney problems, often prescribed or recommended by a clinician. They matter to investors because these meals can lower hospital visits and medication needs—similar to a targeted maintenance plan for a car—creating predictable demand, partnerships with health insurers and hospitals, and potential cost savings that can affect healthcare spending and company revenue.

AI-generated analysis. Not financial advice.

Building on 18 months of proven success, the initiative will scale evidence-based solutions to improve pregnancy and postpartum outcomes for New Yorkers

NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The CVS Health Foundation granted the American Diabetes Association® (ADA) $2.6 million to expand its maternal health initiative to two additional communities within New York City. This expansion builds on the tremendous success of the program's first 18 months, which improved early gestational diabetes (GDM) screening and care coordination for hundreds of patients at Wyckoff Heights Medical Center in Brooklyn. The next phase will bring these life-saving interventions to support more families across New York City throughout the prenatal and postpartum journey, addressing one of the city's most urgent health challenges.

"Over the past 18 months, our work with the American Diabetes Association has delivered tremendous results for New York families," said Jenny McColloch, President of the CVS Health Foundation. "This is why we're boosting our support with a $2.6 million grant to expand this proven program to two additional communities. Together, we're building a model that improves care during pregnancy and sets the foundation for healthier futures for mothers and babies."

Why It Matters for New York

• GDM affects up to 9% of pregnancies nationwide, and rates in New York City have climbed from 6% in 2016 to 8.3% in 2021 according to CDC data.
• In Bushwick, Brooklyn, 19% of adults have diabetes, and avoidable hospitalizations are 70% higher than the city average.

At Wyckoff Heights Medical Center, more than 20% of patients have diabetes, and 56% have an A1C above 9%, signaling dangerously poor blood sugar control.

"Everyone living with diabetes deserves high quality care. Through the collaboration with the CVS Health Foundation, we've been able to open doors to new care opportunities for women with gestational diabetes. We look forward to continuing this important work to increase access to maternal health services and diabetes support," said Osagie Ebekozien, MD, MPH, the ADA's chief quality officer. 

"Wyckoff Heights Medical Center is extremely grateful to continue partnering with the CVS Health Foundation and the American Diabetes Association on phase 2 of an ongoing collaboration to lower diabetes risk, increase care coordination, and improve diabetes care outcomes in our communities with a focus on perinatal health and gestational diabetes. Over the next three years, this project will focus on increasing diabetes screening rates among Wyckoff patients, monitoring, and treatment coordination and will aim to increase access to continuous glucose monitoring and nutrition planning for diabetes management plans," said Vali Gache, chief executive officer for Wyckoff Heights Medical Center.

Program highlights
The next phase of the initiative will expand to two additional sites in New York City, supporting more families throughout the prenatal and postpartum journey in communities with the highest need. This expansion will build enhanced electronic medical records (EMR) dashboards to streamline referrals between obstetricians, primary care practitioners, and endocrinologists, ensuring seamless care transitions. The program will also increase access to advanced diabetes technology, including continuous glucose monitoring (CGM), and provide medically tailored meals (MTMs) to address patients' food insecurity and improve nutrition.

Additionally, the initiative will deliver multilingual education for patients and community health workers, equipping them with the tools to support healthy pregnancies and postpartum care. To measure impact, the program will track patients longitudinally from pregnancy through postpartum, creating a data-driven model for improving maternal health outcomes across New York City.

Real Impact: Patients' Stories
The program supports individuals like C.H., a first-time mom diagnosed with gestational diabetes early in her pregnancy. Initially overwhelmed and unsure what her diagnosis meant, C.H. attended nutritional workshops, worked closely with a community health worker, and learned how to monitor her blood sugar and plan healthy meals.

"Before joining the program, I was overwhelmed and scared. Now, I feel confident and know exactly what to do to keep myself and my baby healthy." — C.H., program participant

About CVS Health Foundation
The CVS Health Foundation has a proud history of supporting local communities across various regions throughout the United States. The Foundation is dedicated to uniting communities to address health challenges in collaboration with a wide range of nonprofit grantees. The Foundation collaborates on programs that enhance health outcomes, with focus areas including mental well-being, healthy aging, maternal health, health impacts from extreme weather and chronic conditions like cardiovascular disease and diabetes. It also helps lay the groundwork for a healthier future by assisting organizations that address food security and promote educational opportunities. Additionally, the CVS Health Foundation supports CVS Health colleagues by backing the causes that are most meaningful to them through its Matching Gifts, Volunteer Challenge Grants and Children of Colleague Scholarship programs.

About the American Diabetes Association 
The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).   

Media Contacts
Courtney Tavener
401-712-3698
Courtney.Tavener@CVSHealth.com

Virginia Cramer
703-253-4927
press@diabetes.org

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cvs-health-foundation-grants-the-american-diabetes-association-2-6-million-to-expand-maternal-diabetes-program-across-two-additional-nyc-communities-302660494.html

SOURCE CVS Health

FAQ

What did CVS announce about the maternal diabetes program on Jan 14, 2026?

CVS funded a $2.6 million grant to the American Diabetes Association to expand a maternal diabetes initiative into two more NYC communities.

How will the CVS-funded program expand gestational diabetes care in NYC?

The program will scale EMR dashboards, increase access to continuous glucose monitoring and provide medically tailored meals and multilingual education.

What results supported CVS's decision to fund the expansion (CVS)?

After 18 months the initiative improved early GDM screening and care coordination for hundreds of patients at Wyckoff Heights Medical Center.

How long will the expanded CVS-funded project run and what will it track?

The project will focus efforts over the next three years and track patients longitudinally from pregnancy through postpartum.

Which New York communities and patient needs does the CVS grant target?

The expansion targets two additional high-need NYC communities with elevated diabetes rates and will address screening, care coordination, nutrition, and food insecurity.